Aminoanthraquinone derivatives to combat multidrug resistance

Sachs, CW., Fine, RL., Ballas, LM., Carroll, RI., & Bell, R. (1995). IPC No. U.S. Aminoanthraquinone derivatives to combat multidrug resistance. (U.S. Patent No. 5436243).

Abstract

Potentiating agents inhibit the development of multidrugresistance, reduce drug-resistance in drug-resistant tumors, orsensitize tumors to antineoplastic drugs, thereby potentiating theeffect of antineoplastic agents. The potentiating agents areaminoanthraquinones, preferably 1,4-bis(N-substituted) aminoanthraquinones, and pharmaceutically acceptable salts thereof.

Download/Explore

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders
Article

Grandi Byen-supporting child growth and development through integrated, responsive parenting, nutrition and hygiene
Article

Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions
Patent

Method of making confined nanocatalysts within mesoporous materials and uses thereof